VISHEE(SH:688580) 智通财经网·2026-02-26 08:20Core Viewpoint - Weisi Medical (688580.SH) reported a robust performance for the fiscal year 2025, with significant increases in both revenue and net profit, indicating strong operational efficiency and effective cost management [1] Financial Performance - The company achieved total operating revenue of 463 million yuan, representing a year-on-year increase of 15.66% [1] - The net profit attributable to the parent company was 137 million yuan, reflecting a year-on-year growth of 33.99% [1] Operational Highlights - The growth in revenue was driven by rapid sales growth of core products [1] - The company focused on cost control, leading to a decrease in period expenses compared to the same period last year, which contributed to the improvement in profitability [1]